Showing results (571-580 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|October 5, 2007
Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cellsK M Wahidur Rahman, Shadan Ali, Amro Aboukameel, et al.
Molecular Cancer Therapeutics|October 5, 2007
The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatmentMark Stettner, Silke Kaulfuss, Peter Burfeind, et al.
Molecular Cancer Therapeutics|October 17, 2006
Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitorJennifer A Seamon, Catherine A Rugg, Stuart Emanuel, et al.
Molecular Cancer Therapeutics|October 17, 2006
Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactionsJinhai Wang, Liusheng He, Christian A Combs, et al.
Molecular Cancer Therapeutics|October 17, 2006
Inhibition of cell growth and nuclear factor-kappaB activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503Her-Shyong Shiah, Wenli Gao, David C Baker, et al.
Molecular Cancer Therapeutics|October 17, 2006
The effect of a novel transition state inhibitor of methylthioadenosine phosphorylase on pemetrexed activityShrikanta Chattopadhyay, Rongbao Zhao, Eugenia Tsai, et al.
Molecular Cancer Therapeutics|October 17, 2006
Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancerLissandra Dal Lago, Virginie Durbecq, Christine Desmedt, et al.
Molecular Cancer Therapeutics|July 9, 2008
Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitorAndrea J Gonzales, Kenneth E Hook, Irene W Althaus, et al.
Molecular Cancer Therapeutics|July 23, 2008
Laser postionization secondary neutral mass spectrometry in tissue: a powerful tool for elemental and molecular imaging in the development of targeted drugsAndrea Wittig, Heinrich F Arlinghaus, Christian Kriegeskotte, et al.
Molecular Cancer Therapeutics|July 23, 2008
Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repairMahmoud Toulany, Rainer Kehlbach, Urszula Florczak, et al.
Pageof 599